Company Filing History:
1 out of 55 
1 out of 5,076 
1 out of 95 
Years Active: 2021
Title: The Innovative Mind of Claire Lhuillier
Introduction
Claire Lhuillier, based in Le Kremlin-Bicetre, France, has made significant contributions to the field of biomedical research. With a focus on immunology, she is recognized for her pioneering work in developing an innovative antibody that targets galectin-9, bringing new hope to treatment methodologies for various diseases, particularly cancer.
Latest Patents
Claire Lhuillier holds a patent for an antibody which is directed against galectin-9. This invention serves as an inhibitor of the suppressor activity of regulatory T lymphocytes. The patent emphasizes the antibody's potential therapeutic applications in treating diseases linked to the suppressor activity of these lymphocytes, showcasing a crucial advancement in cancer treatment.
Career Highlights
Throughout her career, Claire has worked with reputable institutions including Université de Lille and the Centre National de la Recherche Scientifique. Her experiences in these esteemed organizations have positioned her as a leading figure in her field, reflecting her commitment to advancing scientific knowledge and medical applications.
Collaborations
Claire has collaborated with notable colleagues such as Nadira Delhem and Pierre Busson. Their collaborative efforts have further enhanced the research outcomes and the overall impact of their collective work in immunology and therapeutic strategies.
Conclusion
Claire Lhuillier stands out as an innovative inventor whose contributions to antibody research are paving pathways for new therapeutic approaches, particularly in cancer treatment. Her dedication and collaborative efforts continue to inspire advancements in medical science, highlighting the vital role of research and innovation in improving health outcomes.